Gonorrhea screening: Difference between revisions
Jump to navigation
Jump to search
| Line 6: | Line 6: | ||
The table below outlines the screening recommendations for gonorrhea.<ref>{{cite web | title = 2015 Sexually Transmitted Diseases Treatment Guidelines (CDC) | url = http://www.cdc.gov/std/tg2015/screening-recommendations.htm }}</ref> | The table below outlines the screening recommendations for gonorrhea.<ref>{{cite web | title = 2015 Sexually Transmitted Diseases Treatment Guidelines (CDC) | url = http://www.cdc.gov/std/tg2015/screening-recommendations.htm }}</ref> | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
{| | |+ | ||
! Population | ! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Population}} | ||
! | ! style="background: #4479BA; width: 550px;" | {{fontcolor|#FFF|Screening Recommendations}} | ||
|- | |- | ||
| Women | | style="padding: 5px 5px; background: #DCDCDC;" | '''Women''' | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Sexually active women under 25 years of age | * Sexually active women under 25 years of age | ||
* Sexually active women age 25 years and older if at increased risk | * Sexually active women age 25 years and older if at increased risk | ||
**A new sex partner | |||
**More than one sex partner | |||
**A sex partner with concurrent partners | |||
**A sex partner who has a sexually transmitted infection | |||
* Retest 3 months after treatment. | * Retest 3 months after treatment. | ||
|- | |- | ||
| | | style="padding: 5px 5px; background: #DCDCDC;" | '''[[Men Who have Sex With Men (MSM)]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* At least annually for sexually active MSM at sites of contact (urethra, rectum, pharynx) regardless of condom use | |||
* Every 3 to 6 months if at increased risk | |||
| Men Who have Sex With Men (MSM) | |||
| | |||
* At least annually for sexually active MSM at sites of contact (urethra, rectum, pharynx) regardless of condom use | |||
* Every 3 to 6 months if at increased risk | |||
|- | |- | ||
| | | style="padding: 5px 5px; background: #DCDCDC;" | '''Pregnant women''' | ||
| | *All pregnant women under 25 years of age and older women if at increased risk | ||
* For sexually active individuals, screen at first HIV evaluation, and at least annually | *Retest 3 months after treatment | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* | |||
| style="padding: 5px 5px; background: #DCDCDC;" | '''HIV positive patients''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* For sexually active individuals, screen at first HIV evaluation, and at least annually | |||
* More frequent screening for might be appropriate depending on individual risk behaviors and the local epidemiology | * More frequent screening for might be appropriate depending on individual risk behaviors and the local epidemiology | ||
|} | |} | ||
Revision as of 16:22, 15 September 2016
|
Gonorrhea Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Gonorrhea screening On the Web |
|
American Roentgen Ray Society Images of Gonorrhea screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Screening
The table below outlines the screening recommendations for gonorrhea.[1]
| Population | Screening Recommendations | ||
|---|---|---|---|
| Women |
| ||
| [[Men Who have Sex With Men (MSM)] |
| ||
Pregnant women
|
|
HIV positive patients |
|